|
KMID : 0363220140520070494
|
|
Korean Journal of Dermatology
2014 Volume.52 No. 7 p.494 ~ p.497
|
|
|
Development of Renal Disorder in a Patient Receiving Infliximab (Remicadeⓡ) for Psoriasis
|
|
Kim Dae-Hong
Lee Ji-Hyun
Kim Tae-Yoon
|
|
|
Abstract
|
|
|
|
Infliximab (Remicadeⓡ) has been used for treating many chronic inflammatory diseases, including rheumatoid arthritis, ankylosing spondylitis, Crohn`s disease, and psoriasis. Complications such as infusion reaction and infection in infliximab therapy have been reported, but renal complications are rare. We present data on a patient with psoriasis for 15 years who developed new onset renal disorders (IgA nephropathy, acute tubulointerstitial nephritis, acute tubular necrosis) after treatment with infliximab (duration of therapy: 12 months, 8 times). Because the patient with psoriasis receiving infliximab may develop new onset renal disorders, we recommend the evaluation of renal function.
|
|
|
KEYWORD
|
|
|
Chronic inflammatory diseases, Infliximab, Renal disorder
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|